Cornercap Investment Counsel Inc. Decreases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Cornercap Investment Counsel Inc. trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH) by 49.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,835 shares of the company’s stock after selling 15,221 shares during the quarter. Cornercap Investment Counsel Inc.’s holdings in Option Care Health were worth $496,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Harbor Capital Advisors Inc. boosted its holdings in shares of Option Care Health by 317.9% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after buying an additional 73,312 shares in the last quarter. Comerica Bank raised its position in shares of Option Care Health by 6.5% in the 1st quarter. Comerica Bank now owns 760,915 shares of the company’s stock worth $25,521,000 after purchasing an additional 46,639 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of Option Care Health by 182.9% in the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after purchasing an additional 146,837 shares during the last quarter. Edgestream Partners L.P. raised its position in Option Care Health by 96.8% in the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after buying an additional 172,845 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after buying an additional 1,585,818 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 69.02 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Analysts Set New Price Targets

OPCH has been the subject of a number of recent analyst reports. Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Barrington Research reduced their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. JMP Securities upped their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $21.93 on Friday. The stock’s fifty day moving average is $28.62 and its 200 day moving average is $29.38. Option Care Health, Inc. has a fifty-two week low of $21.64 and a fifty-two week high of $34.63. The firm has a market capitalization of $3.73 billion, a PE ratio of 18.43, a PEG ratio of 2.30 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.